Placebo-controlled dietary intervention of stress-induced neurovegetative disorders with a specific amino acid composition: a pilot-study

Table 4 Dietary intake before and after intervention

	Verum (n = 18) \( \overline{\mathrm{x}} \) ± SD		Placebo (n = 14) \( \overline{\mathrm{x}} \) ± SD		V vs. P week 12
	Baseline	Week 12 ^a	Baseline	Week 12 ^a	p ^b
Energy (kcal)	2627 ± 694	2427 ± 556	2453 ± 625	2601 ± 937	0.779
Carbohydrates (g)	280 ± 88	260 ± 77	248 ± 72	275 ± 114	0.543
Protein (g)	103 ± 23	97 ± 28	101 ± 25	106 ± 33	0.470
Fat (g)	114 ± 40	97 ± 25	107 ± 42	107 ± 41	0.879
SFA (g)	43.1 ± 12.3	37.5 ± 14.0	41.4 ± 15.9	38.0 ± 9.4	0.543
MUFA (g)	41.2 ± 19.5	39.7 ± 19.3	35.7 ± 18.1	35.2 ± 10.8	0.909
PUFA (g)	18.8 ± 9.6	18.3 ± 8.9	15.5 ± 7.5	15.8 ± 5.9	0.543
n-6 FA (g)	16.4 ± 9.1	15.9 ± 8.3	12.7 ± 6.6	13.8 ± 5.7	0.569
n-3 FA (g)	2.0 ± 1.1	2.1 ± 0.9	2.5 ± 2.2	1.7 ± 0.8	0.166

abbreviations used: MUFA, monounsaturated fatty acids; n-3 FA, omega-3 fatty acids; n-6 FA, omega-6 fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids.
p-value: ^aWilcoxon-test within groups, ^bMann–Whitney-U test.

ISSN: 1475-2891